Related Experiment Video
Updated: Jun 6, 2026

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Ethyl pyruvate preserves IGF-I sensitivity toward mTOR substrates and protein synthesis in C2C12 myotubes
Robert A Frost1, Erika Pereyra, Charles H Lang
1Department of Cellular and Molecular Physiology (H166), Pennsylvania State University College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, USA. rfrost@psu.edu
Abstract:
Bacterial infection decreases skeletal muscle protein synthesis via inhibition of the mammalian target of rapamycin (mTOR), a key regulator of translation initiation. To better define the mechanism by which muscle mTOR activity is decreased, we used an in vitro model of C2C12 myotubes treated with endotoxin [lipopolysaccharide (LPS)]and interferon (IFN)-γ to determine whether stable lipophilic pyruvate derivatives restore mTOR signaling. Myotubes treated with a combination of LPS and IFNγ down-regulated the phosphorylation of the mTOR substrates S6 kinase-1 and 4E binding protein-1. The phosphorylation of ribosomal protein S6 was decreased, whereas phosphorylation of elongation factor-2 was enhanced; all results consistent with defects in both translation initiation and elongation. LPS/IFNγ decreased protein synthesis 60% in myotubes. Treatment with methyl or ethyl pyruvate partially protected against the LPS/IFNγ-induced fall in mTOR signaling. The protective effect of ethyl and methyl pyruvate could not be replicated by an equimolar amount of sodium pyruvate. Although LPS/IFNγ treated myotubes were initially IGF-I responsive, prolonged exposure (≥ 17 h) resulted in IGF-I resistance at the level of mTOR despite normal IGF-I receptor phosphorylation. Ethyl pyruvate treatment restored IGF-I sensitivity as evidenced by the left shift in the IGF-I dose-response curve and maintained IGF-I responsiveness for a prolonged period of time. Ethyl pyruvate also restored IGF-I-stimulated protein synthesis in LPS/IFNγ-treated myotubes. Cotreatment with N-acetyl cysteine or ascorbic acid also preserved IGF-I sensitivity and mTOR activity. The data suggest that the combination of LPS and IFNγ inhibits mTOR activity and that prolonged exposure induces IGF-I resistance in myotubes. Lipophilic pyruvate derivatives and antioxidants show promise at rescuing mTOR activity and muscle protein synthesis by maintaining IGF-I sensitivity in this model.
Insights
Bacterial infection impairs muscle protein synthesis by inhibiting mTOR signaling. Lipophilic pyruvate derivatives and antioxidants can restore mTOR activity and muscle protein synthesis by maintaining IGF-I sensitivity.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- Bacterial infections disrupt skeletal muscle protein synthesis by inhibiting the mammalian target of rapamycin (mTOR) pathway.
- Understanding the precise mechanisms of mTOR inhibition is crucial for developing therapeutic strategies.
Purpose of the Study:
- To investigate how bacterial endotoxins and cytokines inhibit mTOR signaling in muscle cells.
- To determine if lipophilic pyruvate derivatives can restore mTOR signaling and protein synthesis.
Main Methods:
- C2C12 myotubes were treated with lipopolysaccharide (LPS) and interferon-gamma (IFN-γ) to mimic bacterial infection effects.
- Assessed mTOR signaling by measuring phosphorylation of key substrates like S6 kinase-1 and 4E-binding protein-1.
- Evaluated the impact of methyl pyruvate, ethyl pyruvate, and antioxidants on mTOR activity and insulin-like growth factor-I (IGF-I) sensitivity.
Main Results:
- LPS/IFN-γ treatment significantly reduced protein synthesis and mTOR signaling, affecting both translation initiation and elongation.
- Ethyl and methyl pyruvate partially protected against mTOR inhibition, with ethyl pyruvate showing a more pronounced effect.
- Prolonged LPS/IFN-γ exposure induced IGF-I resistance at the mTOR level, which was reversed by ethyl pyruvate and antioxidants.
- Antioxidants like N-acetyl cysteine and ascorbic acid also preserved mTOR activity and IGF-I sensitivity.
Conclusions:
- Bacterial infection components (LPS/IFN-γ) inhibit mTOR signaling and induce IGF-I resistance in skeletal muscle cells.
- Lipophilic pyruvate derivatives, particularly ethyl pyruvate, and antioxidants show potential in restoring mTOR activity and protein synthesis by maintaining IGF-I sensitivity.
More Related Videos
08:01Measurement of Insulin- and Contraction-Stimulated Glucose Uptake in Isolated and Incubated Mature Skeletal Muscle from Mice
Published on: May 16, 2021
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Fates of Pyruvate
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...